FBRX - Forte Biosciences GAAP EPS of -$0.80 April, 03 2023 12:59 AM Forte Biosciences Inc. 2023-04-03 00:59:15 ET Forte Biosciences press release ( NASDAQ: FBRX ): FY GAAP EPS of -$0.80. Forte ended 2022 with approximately $41.1 million in cash and cash equivalents. For further details see: Forte Biosciences GAAP EPS of -$0.80